EVOK

Handel nachbörslich: 5.86 0.07 +1.21%

Evoke Pharma Inc (EVOK)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Evoke Pharma Inc Stock (EVOK) Company Profile

Evoke Pharma Inc

Healthcare (1182)

858-345-1494

420 STEVENS AVENUE, SOLANA BEACH, CA

Nächster Verdiensttermin

Neueste SEC-Einreichungen

EVOK's Discussions on Twitter

Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2020-06-22	Hochstufung	H.C. Wainwright	Neutral → Buy
2019-03-05	Herabstufung	H.C. Wainwright	Buy → Neutral
2018-03-08	Bestätigt	B. Riley FBR, Inc.	Buy
2017-10-19	Fortgesetzt	FBR & Co.	Buy
2017-03-16	Bestätigt	Rodman & Renshaw	Buy
2017-01-30	Hochstufung	Laidlaw	Neutral → Buy
2017-01-05	Hochstufung	Rodman & Renshaw	Neutral → Buy
2016-12-23	Bestätigt	Rodman & Renshaw	Neutral
2016-07-19	Bestätigt	FBR Capital	Outperform
2016-07-19	Herabstufung	Noble Financial	Buy → Hold
2016-07-18	Herabstufung	Rodman & Renshaw	Buy → Neutral
2016-03-16	Eingeleitet	Northland Capital	Outperform
2016-03-14	Bestätigt	Ascendiant Capital Markets	Buy
2016-02-17	Fortgesetzt	FBR Capital	Outperform
2014-12-03	Bestätigt	MLV & Co	Buy
2014-11-07	Eingeleitet	MLV & Co	Buy
2014-04-22	Eingeleitet	Laidlaw	Buy
2013-11-19	Eingeleitet	Aegis Capital	Buy

Alle ansehen

Evoke Pharma Inc Aktie (EVOK) Neueste Nachrichten

Finanzdaten der Evoke Pharma Inc-Aktie (EVOK)

Evoke Pharma Inc (EVOK)

Evoke Pharma Inc Stock (EVOK) Company Profile

Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades

Evoke Pharma Inc Aktie (EVOK) Neueste Nachrichten

Gastroparesis Drugs Market to Grow by USD 1.42 Billion from 2024-2028, Driven by Rising Diabetes Rates and AI-Driven Market Trend InsightsTechnavio - PR Newswire

Evoke Pharma, Inc.'s (NASDAQ:EVOK) Shift From Loss To Profit - Yahoo Finance

Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews.com - Defense World

Global Digestive Health Market Size, Share And Growth Analysis For 2024-2033 - EIN News

Canopy Growth Corporation (CGC) Stock Price, News, Quote & History - Yahoo Finance

Evoke Pharma (FRA:EV0) Enterprise Value : €1.02 Mil (As of Nov. 01, 2024) - GuruFocus.com

Gastroparesis Treatment Market Top Trends and Growth Analysis: - openPR

When Will Evoke Pharma, Inc. (NASDAQ:EVOK) Become Profitable? - Simply Wall St

Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket - Benzinga

Five things for pharma marketers to know for Tuesday morning - MM+M Online

Evoke Pharma holds Buy rating with $18 target from Laidlaw - Investing.com

S&P 500 Moves Higher; Philips Shares Plunge After Q3 EarningsKoninklijke Philips (NYSE:PHG) - Benzinga

Monte Rosa Therapeutics, Evoke Pharma, and Autonomix Medical: The Top 3 Stocks Capturing Retail Attention - Barchart

Evoke Pharma Shares Soar on Positive Data for Gimoti Nasal Treatment in Diabetic Gastroparesis - Yahoo Finance

What made Evoke Pharma stock more than double on Monday? - Invezz

Crude Oil Tumbles Over 5%; Autonomix Medical Shares Spike Higher - Benzinga

Evoke Pharma Shares Rise 70% on Gimoti Data in GLP-1 Users - MarketWatch

Evoke stock rockets 90% on study of Gimoti in GLP-1 users (NASDAQ:EVOK) - Seeking Alpha

Dow Jumps Over 300 Points; ON Semiconductor Earnings Top ViewsHealthcare Triangle (NASDAQ:HCTI) - Benzinga

Pre-market Movers: EVOK, HCTI, GLUE, MNPR... - RTTNews

Evoke Pharma Stock Is Soaring Monday: What's Going On? - Benzinga

Evoke Pharma reports significant benefits of GIMOTI in DGP study - Investing.com India

Evoke Pharma & EVERSANA Announce Statistically Significant - GlobeNewswire

Evoke Pharma & EVERSANA Announce Statistically Significant Improvement in Patient Outcomes for GLP-1 users with Diabetic Gastroparesis using GIMOTI® - StockTitan

Gastroparesis Drugs Market: Size, Share, Trends, and Forecast for 2024-2033 - openPR

Global Manufacturer and Distributor Chooses Bridgeline's AI-Powered HawkSearch - The Manila Times

Evoke Pharma to Showcase Award-Winning Research at the 2024 American College of Gastroenterology Annual Scientific Meeting - The Manila Times

Evoke Pharma to Showcase Award-Winning Research at the 2024 - GlobeNewswire

Evoke Pharma appoints Benjamin Smeal as new director By Investing.com - Investing.com Canada

Evoke Pharma appoints Benjamin Smeal as new director - Investing.com India

Evoke Pharma Appoints Benjamin Smeal as Director - TipRanks

Evoke Pharma, Inc. Appoints Benjamin Smeal to Serve as Class II Director - Marketscreener.com

Evoke Pharma appoints new board member Ben Smeal - Investing.com India

Sky Quarry to Present at The ThinkEquity Conference on Wednesday, October 30, 2024 - The Manila Times

Evoke Pharma Announces the Appointment of Ben Smeal to the Board of Directors - GlobeNewswire

iRobot (NASDAQ:IRBT) Raised to Hold at StockNews.com - Defense World

Evoke Pharma secures lease extension for headquarters - Investing.com India

(EVOK) Technical Data - Stock Traders Daily

Evoke Pharma secures lease extension for headquarters By Investing.com - Investing.com Canada

Digestive and Intestinal Remedies Market Growth Analysis with Investment Opportunities For 2024-2033 - EIN News

Gastroparesis Drugs Market Opportunities, Challenges, - openPR

Breakthroughs in Diabetic Gastroparesis Treatment: What to Expect in 2024 - WhaTech

South Korea Posture Correction Market Size & Outlook, 2030 - Grand View Research

Gastroparesis Market Expected to Experience Major Growth - openPR

Gastroparesis Treatment Market Size, Demand, Trends, Analysis - openPR

Evoke Pharma (NASDAQ:EVOK) Now Covered by StockNews.com - Defense World

Evoke Pharma secures $3 million from warrant exercises - Investing.com

Scorpio Tankers Announces Vessel Sale Agreement - The Manila Times

Evoke Pharma Announces Proceeds from Existing Warrants and Board Expansion - GlobeNewswire

Tesla Inc (TSLA-Q) QuotePress Release - The Globe and Mail

Evoke Pharma amends warrants, secures $2.4 million funding By Investing.com - Investing.com South Africa

Finanzdaten der Evoke Pharma Inc-Aktie (EVOK)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie EVOK